Literature DB >> 15710972

Microbes, immunoregulation, and the gut.

G A W Rook1, L R Brunet.   

Abstract

Two distinct, but rapidly converging, areas of research (the hygiene hypothesis and the study of probiotic/prebiotic effects) have emphasised the need to understand, and ultimately to manipulate, our physiological interactions with commensal flora, and with other transient but harmless organisms from the environment that affect immunoregulatory circuits. The story began with allergic disorders but now inflammatory bowel disease is increasingly involved.

Entities:  

Mesh:

Year:  2005        PMID: 15710972      PMCID: PMC1774411          DOI: 10.1136/gut.2004.053785

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  39 in total

Review 1.  Probiotics in inflammatory bowel disease: is it all gut flora modulation?

Authors:  S Ghosh; D van Heel; R J Playford
Journal:  Gut       Date:  2004-05       Impact factor: 23.059

2.  Cutting edge: TGF-beta induces a regulatory phenotype in CD4+CD25- T cells through Foxp3 induction and down-regulation of Smad7.

Authors:  Massimo C Fantini; Christoph Becker; Giovanni Monteleone; Francesco Pallone; Peter R Galle; Markus F Neurath
Journal:  J Immunol       Date:  2004-05-01       Impact factor: 5.422

3.  Is the mucosal route of administration essential for probiotic function? Subcutaneous administration is associated with attenuation of murine colitis and arthritis.

Authors:  B Sheil; J McCarthy; L O'Mahony; M W Bennett; P Ryan; J J Fitzgibbon; B Kiely; J K Collins; F Shanahan
Journal:  Gut       Date:  2004-05       Impact factor: 23.059

Review 4.  Mycobacteria and other environmental organisms as immunomodulators for immunoregulatory disorders.

Authors:  G A W Rook; V Adams; J Hunt; R Palmer; R Martinelli; L Rosa Brunet
Journal:  Springer Semin Immunopathol       Date:  2003-10-08

5.  Toll-like receptor 9 signaling mediates the anti-inflammatory effects of probiotics in murine experimental colitis.

Authors:  Daniel Rachmilewitz; Kyoko Katakura; Fanny Karmeli; Tomoko Hayashi; Constantin Reinus; Bernard Rudensky; Shizuo Akira; Kiyoshi Takeda; Jongdae Lee; Kenji Takabayashi; Eyal Raz
Journal:  Gastroenterology       Date:  2004-02       Impact factor: 22.682

6.  Mycobacterium vaccae induces a population of pulmonary CD11c+ cells with regulatory potential in allergic mice.

Authors:  Victoria C Adams; Jon R F Hunt; Roberta Martinelli; Rebecca Palmer; Graham A W Rook; Laura Rosa Brunet
Journal:  Eur J Immunol       Date:  2004-03       Impact factor: 5.532

7.  Cohort study of sibling effect, infectious diseases, and risk of atopic dermatitis during first 18 months of life.

Authors:  Christine Stabell Benn; Mads Melbye; Jan Wohlfahrt; Bengt Björkstén; Peter Aaby
Journal:  BMJ       Date:  2004-04-30

Review 8.  Therapeutic manipulation of the enteric microflora in inflammatory bowel diseases: antibiotics, probiotics, and prebiotics.

Authors:  R Balfour Sartor
Journal:  Gastroenterology       Date:  2004-05       Impact factor: 22.682

9.  Defective suppressor function of human CD4+ CD25+ regulatory T cells in autoimmune polyglandular syndrome type II.

Authors:  Martin A Kriegel; Tobias Lohmann; Christoph Gabler; Norbert Blank; Joachim R Kalden; Hanns-Martin Lorenz
Journal:  J Exp Med       Date:  2004-04-26       Impact factor: 14.307

10.  Loss of functional suppression by CD4+CD25+ regulatory T cells in patients with multiple sclerosis.

Authors:  Vissia Viglietta; Clare Baecher-Allan; Howard L Weiner; David A Hafler
Journal:  J Exp Med       Date:  2004-04-05       Impact factor: 14.307

View more
  76 in total

1.  Role of interleukin (IL-10) in probiotic-mediated immune modulation: an assessment in wild-type and IL-10 knock-out mice.

Authors:  B Sheil; J MacSharry; L O'Callaghan; A O'Riordan; A Waters; J Morgan; J K Collins; L O'Mahony; F Shanahan
Journal:  Clin Exp Immunol       Date:  2006-05       Impact factor: 4.330

Review 2.  Primary Prevention of Food Allergy.

Authors:  Rachel L Peters; Melanie R Neeland; Katrina J Allen
Journal:  Curr Allergy Asthma Rep       Date:  2017-08       Impact factor: 4.806

3.  Oral administration of Alequel, a mixture of autologous colon-extracted proteins for the treatment of Crohn's disease.

Authors:  Eran Israeli; Yaron Ilan
Journal:  Therap Adv Gastroenterol       Date:  2010-01       Impact factor: 4.409

Review 4.  The gut flora as a forgotten organ.

Authors:  Ann M O'Hara; Fergus Shanahan
Journal:  EMBO Rep       Date:  2006-07       Impact factor: 8.807

Review 5.  What is the origin of ulcerative colitis? Still more questions than answers.

Authors:  Milan Lukas; Martin Bortlik; Zdenek Maratka
Journal:  Postgrad Med J       Date:  2006-10       Impact factor: 2.401

Review 6.  Proposed model: mechanisms of immunomodulation induced by probiotic bacteria.

Authors:  C Maldonado Galdeano; A de Moreno de LeBlanc; G Vinderola; M E Bibas Bonet; G Perdigón
Journal:  Clin Vaccine Immunol       Date:  2007-03-14

Review 7.  Genes and molecules of lactobacilli supporting probiotic action.

Authors:  Sarah Lebeer; Jos Vanderleyden; Sigrid C J De Keersmaecker
Journal:  Microbiol Mol Biol Rev       Date:  2008-12       Impact factor: 11.056

8.  Relationship between various Chinese medicine types and T-cell subsets in patients with ulcerative colitis.

Authors:  Ting-min Chang; Xiu-min Li; Xi-de Zhao
Journal:  Chin J Integr Med       Date:  2009-07-02       Impact factor: 1.978

Review 9.  Surveying Gut Microbiome Research in Africans: Toward Improved Diversity and Representation.

Authors:  Ryan Brewster; Fiona B Tamburini; Edgar Asiimwe; Ovokeraye Oduaran; Scott Hazelhurst; Ami S Bhatt
Journal:  Trends Microbiol       Date:  2019-06-06       Impact factor: 17.079

Review 10.  Helicobacter pylori infection and inflammatory bowel disease in Asians: a meta-analysis.

Authors:  Xiao-Wei Wu; Hong-Zan Ji; Miao-Fang Yang; Lin Wu; Fang-Yu Wang
Journal:  World J Gastroenterol       Date:  2015-04-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.